These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 14991904

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Expression of proteasome subunit β5t in thymic epithelial tumors.
    Yamada Y, Tomaru U, Ishizu A, Kiuchi T, Marukawa K, Matsuno Y, Kasahara M.
    Am J Surg Pathol; 2011 Sep; 35(9):1296-304. PubMed ID: 21836487
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma.
    Holst VA, Marshall CE, Moskaluk CA, Frierson HF.
    Mod Pathol; 1999 Oct; 12(10):956-60. PubMed ID: 10530560
    [Abstract] [Full Text] [Related]

  • 10. Tyrosine kinase receptor expression in thymomas.
    Henley JD, Cummings OW, Loehrer PJ.
    J Cancer Res Clin Oncol; 2004 Apr; 130(4):222-4. PubMed ID: 14762710
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K, Göke F, Nettersheim D, Eckert D, Zhou H, Kahl P, Gashaw I, Schorle H, Büttner R.
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Thymic carcinoma: is it a separate entity? From molecular to clinical evidence.
    Marx A, Rieker R, Toker A, Länger F, Ströbel P.
    Thorac Surg Clin; 2011 Feb; 21(1):25-31. v-vi. PubMed ID: 21070984
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The MIC2 antibody 013. Practical application for the study of thymic epithelial tumors.
    Chan JK, Tsang WY, Seneviratne S, Pau MY.
    Am J Surg Pathol; 1995 Oct; 19(10):1115-23. PubMed ID: 7573670
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Kit (CD117) immunoreactivity is rare in renal cell and upper urinary tract transitional cell carcinomas.
    Zigeuner R, Ratschek M, Langner C.
    BJU Int; 2005 Feb; 95(3):315-8. PubMed ID: 15679785
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.